Electrical computers and digital processing systems: multicomput – Computer conferencing – Cooperative computer processing
Reexamination Certificate
2011-03-15
2011-03-15
Jean Gilles, Jude J (Department: 2447)
Electrical computers and digital processing systems: multicomput
Computer conferencing
Cooperative computer processing
C709S206000, C717S101000, C717S178000, C715S781000, C715S861000, C715S764000, C715S770000, C715S247000
Reexamination Certificate
active
07908323
ABSTRACT:
A system for acquiring, sharing and managing information in an organization is disclosed hereinafter. The system involves a network communicator for connecting to a network through which users accesses the system, and a document manager through which a user provides a document for access by at least one other user through the network. The system also involves electronic conversing means for enabling a user to correspond with at least one other user through the network using an electronic conversation format for generating an electronic conversation record, and an archive for storing at least one of documents provided through the document manager and electronic conversation record conducted using the electronic conversing means. In the system, a keyword representative of the at least one of documents and electronic conversation record is stored in the archive in association with the stored at least one documents and electronic conversation record.
REFERENCES:
patent: 5208748 (1993-05-01), Flores et al.
patent: 5573924 (1996-11-01), Beckmann et al.
patent: 6003137 (1999-12-01), Kawasaki
patent: 6214345 (2001-04-01), Firestone et al.
patent: 6342219 (2002-01-01), Thorpe et al.
patent: 6405179 (2002-06-01), Rebane
patent: 6884869 (2005-04-01), Senter et al.
patent: 7089278 (2006-08-01), Churchill et al.
patent: 2001/0007332 (2001-07-01), Andreas et al.
patent: 2002/0013759 (2002-01-01), Dalal et al.
patent: 2003/0083263 (2003-05-01), Doronina et al.
patent: 2003/0096743 (2003-05-01), Senter et al.
patent: 2003/0130189 (2003-07-01), Senter et al.
patent: 2004/0157782 (2004-08-01), Doronina et al.
patent: 2005/0113308 (2005-05-01), Senter et al.
patent: 2005/0118656 (2005-06-01), Terrett
patent: 2005/0123547 (2005-06-01), Terrett
patent: 2005/0238649 (2005-10-01), Doronina et al.
patent: 2001 344400 (2001-12-01), None
patent: 2002 049729 (2002-02-01), None
patent: WO 00/13122 (2000-03-01), None
patent: WO 02/088172 (2002-11-01), None
patent: WO 03/026577 (2003-04-01), None
patent: WO 03/046581 (2003-06-01), None
patent: WO 2005/081711 (2005-09-01), None
PCT International Search Report for PCT/SG02/00088 dated Jun. 28, 2002.
Agathanggelou et al., “Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells,”Am J. Pathol., 147(4):1152-1160 (1995).
Agematsu et al., “Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction,”Blood, 91(1):173-180 (1998).
Agematsu et al., “B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production,”Eur. J. Immunol., 27(8):2073-2079 (1997).
Akiba et al., “Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis,”J. Exp. Med., 191(2):375-380 (2000).
Bahler et al., “Clonal evolution of a follicular lymphoma: evidence for antigen selection,”PNAS, 89(15):6770-6774 (1992).
Bahler et al., “Antigen selection in human lymphomagenesis,”Cancer Res., 52(19 Suppl.):5547s-5551s (1992).
Bowman et al., “The cloning of CD70 and its identification as the ligand for CD27,”J. Immunol., 152(4):1756-1761 (1994).
Brugnoni et al., “CD70 expression on T-cell subpopulations: study of normal individuals and patients with chronic immune activation,”Immunol. Lett., 55(2):99-104 (1997).
De Jong et al., “Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors,”J. Immunol., 146(8):2488-2494 (1991).
Den Haan et al., “Identification of a graft versus host disease-associated human minor histocompatibility antigen,”Science, 268(5216):1476-1480 (1995).
Dillman, R. O., “Monoclonal Antibodies for Treating Cancer,”Ann. Int. Med., 111:592-603 (1989).
Giralt et al., “Leukemia relapse after allogeneic bone marrow transplantation: a review,”Blood, 84(11):3603-3612 (1994).
Goodwin et al., “Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor,”Cell, 73(3):447-456 (1993).
Gravestein et al., “Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family,”Eur. J. Immunol., 23(4):943-950 (1993).
Gravestein et al., “Novel mAbs reveal potent co-stimulatory activity of murine CD27,”Int. Immunol., 7(4):551-557 (1995).
Gruss et al., “Pathophysiology of Hodgkin's disease: functional and molecular aspects,”Baillieres Clin. Haematol., 9(3):417-446 (1996).
Held-Feindt et al., “CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors,”Int. J. Cancer, 98(3):352-356 (2002).
Hintzen et al., “CD70 represents the human ligand for CD 27,”Int. Immunol., 6(3):477-480 (1994).
Hintzen et al., “Characterization of the human CD27 ligand, a novel member of the TNF gene family,”J. Immunol., 152(4):1762-773 (1994).
Hintzen et al., “CD27: marker and mediator of T-cell activation?,”Immunol. Today, 15(7):307-311 (1994).
Hintzen et al., “Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation,”J. Immunol., 154(6):2612-2623 (1995).
Hintzen et al., “Regulation of CD27 expression on subsets of mature T-lymphocytes,”J. Immunol., 151(5):2426-2435 (1993).
Hintzen et al., “A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex,”J. Immunol., 147(1):29-35 (1991).
Hishima et al., “CD70 expression in thymic carcinoma,”Am. J. Surg. Pathol., 24(5):742-746 (2000).
Jacquot et al., “CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling,”J. Immunol., 159(6):2652-2657 (1997).
Kobata et al., “CD27-CD70 interactions regulate B-cell activation by T cells,”PNAS, 92(24):11249-11253 (1995).
Lens et al., “Aberrant expression and reverse signaling of CD70 on malignant B cells,”Br. J. Haematol., 106(2):491-503 (1999).
Lens et al., “Phenotype and function of human B cells expressing CD70 (CD27 ligand),”Eur. J. Immunol., 26(12):2964-2971 (1996).
Lens et al., “Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells,”Immunol., 90:38-45 (1997).
Lens et al., “Control of lymphocyte function through CD27-CD70 interactions,”Semin Immunol., 10(6):491-499 (1998).
Locksley et al., “The TNF and TNF receptor superfamilies: integrating mammalian biology,”Cell, 104(4):487-501 (2001).
Maurer et al., “CD27 expression by a distinct subpopulation of human B lymphocytes,”Eur. J. Immunol., 20(12):2679-2684 (1990).
Nakajima et al., “Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis,”J. Neuroimmunol., 109(2):188-196 (2000).
Nakajima et al., “Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice,”J. Immunol., 158(3):1466-1472 (1997).
Orengo et al., “Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity,”Clin. Exp. Immunol., 107(3):608-613 (1997).
Oshima et al., “Characterization of murine CD70 by molecular cloning and mAb,”Int. Immunol., 10(4):517-526 (1998).
Peitsch et al., “Comparative molecular modeling of the Fas-ligand and other members of the TNF family,”Mol. Immunol., 32(10):761-772 (1995).
Smith et al., “A receptor for tumor necrosis
Gilles Jude J Jean
Pi Eta Consulting Company Pte. Ltd.
Sawyer Law Group P.C.
LandOfFree
Enterprise knowledge and information acquisition, management... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enterprise knowledge and information acquisition, management..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enterprise knowledge and information acquisition, management... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2664647